Cardiff Oncology (STU:XE7C) Profitability Rank : 1 (As of Dec. 2023)

Competitive Comparison of Cardiff Oncology's Profitability Rank

For the Biotechnology subindustry, Cardiff Oncology's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardiff Oncology's Profitability Rank Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cardiff Oncology's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Cardiff Oncology's Profitability Rank falls into.

Cardiff Oncology Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Cardiff Oncology has the Profitability Rank of 1. It has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Cardiff Oncology's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Cardiff Oncology has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

Warning Sign:

Cardiff Oncology Inc operating margin has been in a 5-year decline. The average rate of decline per year is -17%.

4. Consistency of the profitability

5. Predictability Rank

Cardiff Oncology Profitability Rank Related Terms

Thank you for viewing the detailed overview of Cardiff Oncology's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardiff Oncology (STU:XE7C) Business Description